itmcweb

About Karen

This author has not yet filled in any details.
So far Karen has created 60 blog entries.

Right to Try Bills Push the Needle on Risk’ –  panel of experts, including WCGF Executive Director Marjorie A. Speers, discuss risks associated with Right-to-Try legislation

Published December 24, 2017 by OncLive

“Congressional “right-to-try” legislation could make investigational drugs available to desperately ill patients sooner in the trials process, but there are substantial risks, said a panel of experts at the Patient-Centered Oncology Conference, held November 16-17 in Philadelphia, Pennsylvania.

Earlier in the clinical trials process, less is known about the drugs, which […]

2018-07-02T14:50:44-04:00December 24, 2017|News|

Could #breastcancer be prevented from spreading to the brain?

For women whose breast cancer metastasizes, the disease is generally incurable. Often, these metastases move to the brain, even further limiting treatment options. A new clinical trial is trying to determine if a medication, temozolomide, could prevent breast cancer from metastasizing to the brain. For more on this study, read this from the

2017-11-29T06:24:09-05:00December 22, 2017|General|

#AntibioticResistance could lead to dangerous outcomes. What can be done to prevent this?

The use, and overuse, of antibiotics is of serious concern in the United States. It is believed that over 80% of prescribed antibiotics are unnecessary, which could lead to antibiotic resistance, possibly leading to a return of the time when simple infections were fatal. To avoid this outcome, it is essential that patients and physicians […]

2017-11-29T06:24:16-05:00December 19, 2017|General|

What were the first molecules that led to life on Earth?

Much is speculated and studied about the origins of life on Earth. For decades, scientists have believed that the first molecule that led to living beings was RNA. However, questions have remained about the viability of that theory, as RNA is very complicated and sensitive. New computer modeling suggests that proteins, not RNA were the […]

2017-11-29T06:24:22-05:00December 15, 2017|General|

3-Reasons to Give

In 2016, a record $390 billion was contributed to charities by individuals, corporations and foundations in the United States, making America the most generous nation in the world.

This giving spirit is reflective of Americans across socio-economic lines, with almost one-third of contributions directed to religious organizations and 20% directed to health and human services organizations.

People […]

2018-05-25T16:30:55-04:00December 13, 2017|General|

Could there be a link between #football / #soccer and #CTE?

While the link between American football and CTE is being investigated, we may not realize that post-mortem studies are also being conducted to find a link between soccer and CTE. It seems that many retired professional soccer players have suffered from dementia and the onset of the disease was unusually young in these players. Studies […]

2017-11-29T06:24:34-05:00December 12, 2017|General|

How can our society study and regulate the offerings of popular, but unproven, regenerative medicine?

Advances have been made in the field of stem cell therapy, but the expansion of therapies offered, some with, some without, a deep level of research, has grown significantly. Many Americans are traveling to other countries with less rigorous testing requirements to access these therapies. But because the range of the available unproven treatments is […]

2017-11-29T06:24:40-05:00December 8, 2017|General|

How did physicians use a discovery from a recent #clinicaltrial to save the life of a boy with a dangerous skin condition?

Using a discovery involving the boy’s own stem cells, physicians were able to save the life of a boy with a dangerous genetic skin condition. The patient, who was suffering from junctional epidermolysis bullosa, in which the skin sheds the epidermis, had lost over eighty percent of his top layer of skin. Through the growth […]

2017-11-29T06:24:47-05:00December 5, 2017|General|

How is the FDA widening the scope of the Reagan Udall Expanded Access Navigator to assist patients with rare or orphan diseases?

Patients with rare diseases face unique challenges. Often, there may be no FDA approved treatments for them, or the patient population with an orphan disease is very small – it may be difficult to find clinical trials developing medicine for their diseases. For this reason, the FDA is expanding the use of the Reagan-Udall Foundation’s […]

2017-11-29T06:24:53-05:00December 1, 2017|General|
Load More Posts